Stockreport

enGene Maps BLA by End-2026, Targets 2027 Launch for Lead NMIBC Therapy at Oppenheimer Conference [Yahoo! Finance]

enGene Holdings Inc.  (ENGN) 
PDF The LEGEND pivotal cohort completed enrollment at 125 patients, and post-amendment data from 62 of 94 patients showed roughly a 62% six-month complete response (CR) wit [Read more]